Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bacterial Septicemia”

511 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 511 results

Early research (Phase 1)Study completedNCT02439359
What this trial is testing

A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects

Who this might be right for
Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
ContraFect 20
Not applicableStudy completedNCT04821661
What this trial is testing

T2 and SeptiCyte RAPID Duration Project

Who this might be right for
Bacteremia
The University of Queensland 102
Not applicableStudy completedNCT00913042
What this trial is testing

Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia

Who this might be right for
FebrileNeutropeniaPost-chemotherapy
Assistance Publique - Hôpitaux de Paris 120
Early research (Phase 1)Study completedNCT03162250
What this trial is testing

Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics

Who this might be right for
Bacteremia
Genentech, Inc. 27
Not applicableStudy completedNCT01359891
What this trial is testing

Clinical Evaluation of Novel Biomarkers in Patients With Septicemia

Who this might be right for
SepsisBacteremiaFungemia
Medical University of Graz 750
Not applicableStudy completedNCT05259683
What this trial is testing

Febrile Infant Diagnostic Assessment and Outcome Study

Who this might be right for
Urinary Tract InfectionsMeningitisSepsis+1 more
Queen's University, Belfast 2,076
Large-scale testing (Phase 3)Looking for participantsNCT04750070
What this trial is testing

Management of Shock in Children With SAM or Severe Underweight and Diarrhea

Who this might be right for
Shock HypovolemicShock, SepticBlood Transfusion+2 more
International Centre for Diarrhoeal Disease Research, Bangladesh 135
Not applicableStudy completedNCT01663701
What this trial is testing

Simplified Severe Sepsis Protocol-2 (SSSP-2) in Zambia

Who this might be right for
SepsisSevere SepsisTuberculosis
Vanderbilt University 212
Post-approval studies (Phase 4)Ended earlyNCT01734694
What this trial is testing

Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients

Who this might be right for
Health Care Associated PneumoniaOsteomyelitis/Septic ArthritisEndocarditis+2 more
Henry Ford Health System 100
Not applicableStudy completedNCT06958354
What this trial is testing

Evaluation of the Clinical Relationship Between Procalcitonin Level and Bacteremia Agent in Intensive Care Unit Patients

Who this might be right for
SepsisSepticBacteremia and Sepsis+2 more
Gulhane Training and Research Hospital 1,529
Not applicableStudy completedNCT01752166
What this trial is testing

Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study)

Who this might be right for
Candidemia
T2 Biosystems 1,500
Not applicableStudy completedNCT01184339
What this trial is testing

Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives

Who this might be right for
Bacteremia
MicroPhage, Inc. 1,165
Post-approval studies (Phase 4)Ended earlyNCT00638157
What this trial is testing

Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)

Who this might be right for
Infective Endocarditis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 24
Post-approval studies (Phase 4)Ended earlyNCT03756454
What this trial is testing

Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery.

Who this might be right for
Clostridia Difficile ColitisClostridium; Sepsis
Michael E Villarreal, MD 5
Post-approval studies (Phase 4)Study completedNCT00548262
What this trial is testing

This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis

Who this might be right for
CandidemiaInvasive Candidiasis
Pfizer 54
Not applicableUnknownNCT02098850
What this trial is testing

Staphylococcus Aureus Bacteraemia in Adults

Who this might be right for
Staphylococcus Aureus Bacteremia
University of Cologne 2,000
Large-scale testing (Phase 3)Ended earlyNCT00518687
What this trial is testing

Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)

Who this might be right for
Staphylococcus AureusBacteremiaMediastinitis
Merck Sharp & Dohme LLC 8,031
Large-scale testing (Phase 3)Study completedNCT00761267
What this trial is testing

Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis

Who this might be right for
Candidemia
Pfizer 70
Not applicableStudy completedNCT06174519
What this trial is testing

Evaluation of the Artificial Intelligence-based Prescription Support Software iAST® for the Choice of Empirical and Semi-targeted Antibiotic Treatment

Who this might be right for
Bacterial Infections
Pragmatech AI Solutions 325
Large-scale testing (Phase 3)Ended earlyNCT00055198
What this trial is testing

Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria

Who this might be right for
Gram-Positive Bacterial Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 75
Load More Results